BackRelay Therapeutics Overview
Relay Therapeutics Inc

Relay Therapeutics Target Price

Analysts' average 12-month price target for Relay Therapeutics is $26.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.07

Average Target Price

$25.7328.2% upside

11 analysts in the last 4 months

High: $31 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07BarclaysEtzer Darout$3049.5% upsideOpen
2026-07-21Goldman SachsSalveen Richter$3154.5% upsideOpen
2026-07-16Canaccord GenuityJohn Newman$2944.5% upsideOpen
2026-05-26GuggenheimBrad Canino$2629.5% upsideOpen
2026-05-26H.C. Wainwright$2839.5% upsideOpen
2026-05-20Barclays$2734.5% upsideOpen
2026-05-19UBS$2629.5% upsideOpen
2026-04-29H.C. Wainwright$2524.6% upsideOpen
2026-04-28Oppenheimer$1810.3% downsideOpen
2026-04-28Wells Fargo$214.6% upsideOpen
2026-04-28Goldman SachsSalveen Richter$229.6% upsideOpen
2026-03-13GuggenheimBrad Canino$229.6% upsideOpen
2026-01-26Oppenheimer$1430.2% downsideOpen
2025-12-12Wells Fargo$1335.2% downsideOpen
2024-09-16H.C. WainwrightRobert Burns$195.3% downsideOpen
2024-09-10JefferiesAkash Tewari$1620.3% downsideOpen
2024-09-09BarclaysPeter Lawson$1715.3% downsideOpen
2024-09-04Bank of America SecuritiesJason Gerberry$200.3% downsideOpen
2024-05-10BarclaysPeter Lawson$1525.3% downsideOpen
2024-05-06OppenheimerMatt Biegler$2524.6% upsideOpen
2023-04-20JefferiesAkash Tewari$12.537.7% downsideOpen
2023-02-03Oppenheimer$3364.4% upsideOpen
2022-09-30BarclaysPeter Lawson$2314.6% upsideOpen

Relay Therapeutics (RLAY) FAQ

Relay Therapeutics (RLAY) currently reports a target price of $26. Use the charts on this page to explore Relay Therapeutics's target price history and peer comparisons.

Analysts' average 12-month price target for Relay Therapeutics is $26, about 28.2% upside from the current share price of $20.07. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $26, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Relay Therapeutics, and consider following RLAY for alerts when major investors trade the stock.

Relay Therapeutics is classified in the Healthcare sector. On target price, it currently shows $26. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RLAY with unrelated industries.